AMAT
49
-3
WYNN
34
-3
THC
61
3
MNST
52
2
FLS
46
-7
APD
42
-2
SWN
70
3
HRL
38
2
BWA
42
-2
AEP
59
-3
AVY
54
-14
GOOGL
53
2
VRSN
50
-5
BAC
39
-2
DLTR
31
3
GOOG
63
2
AEE
61
-2
AIZ
71
-2
NRG
57
2
BLK
69
2
AMAT
49
-3
WYNN
34
-3
THC
61
3
MNST
52
2
FLS
46
-7
APD
42
-2
SWN
70
3
HRL
38
2
BWA
42
-2
AEP
59
-3
AVY
54
-14
GOOGL
53
2
VRSN
50
-5
BAC
39
-2
DLTR
31
3
GOOG
63
2
AEE
61
-2
AIZ
71
-2
NRG
57
2
BLK
69
2
Financhill
Back

PeptiDream 10K Form

Buy
72

PPTDF
PeptiDream

Last Price:
17.00
Seasonality Move:
-12.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PPTDF News And Ratings

See the #1 stock for the next 7 days that we like better than PPTDF

PPTDF Financial Statistics

Sales & Book Value

Annual Sales: $204.65M
Cash Flow: $-6.87M
Price / Cash Flow: 0
Annual Sales: $2.82
Price / Book: 6.03

Profitability

EPS (TTM): 1.08530
Net Income (TTM): $140.85M
Gross Margin: $122.73M
Return on Equity: 51.02%
Return on Assets: 29.47%

PeptiDream Earnings Forecast

Key PeptiDream Financial Ratios

  • The Gross Profit Margin over the past 12 years for PPTDF is 59.97%.
  • The Selling, General & Administrative Expenses for PPTDF have been equal to 25.27% of Gross Profit Margin.
  • The Research & Development expenses have been 10.99% of Revenue.
  • The Interest Expense is 74.21% of Operating Income.
  • The Net Earning history of PPTDF is 10.57% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

PeptiDream Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: PPTDF
Website: peptidream.com

Debt

Debt-to-Equity Ratio: 0.36
Current Ratio: 3.39
Quick Ratio: 3.19

Price-to-Earnings

Trailing P/E Ratio: 102.02
Forward P/E Ratio: 0

PPTDF Technical Analysis vs Fundamental Analysis

Buy
72
PeptiDream (PPTDF) is a Buy

Is PeptiDream a Buy or a Sell?

  • PeptiDream stock is rated a Buy
    The current PeptiDream [PPTDF] share price is $17.00. The Score for PPTDF is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.